SlideShare a Scribd company logo
Is there a need for a Rare Disease Nurse
Network for patients with rare diseases?
The Team
Natalie
Rebeyev
Engagement
Manager
Chun Hui
Lien
Senior
Consultant
Cason Chan
Consultant
Vidit Doshi
Consultant
Hanyuying
(Sherry)
Wang
Consultant
Saakshi
Chadha
Consultant
2
1 Demand for a telemedicine pilot program
Operational requirements of a telemedicine pilot
Cost of a potential telemedicine pilot program3
4 Rare Disease Nurse Network
1
Content
2
3
Executive Summary
● There is strong demand for a telemedicine pilot program from rare
disease patients. Our survey findings indicates that a majority of patients
are receptive to a telemedicine pilot -- over 50% believe telemedicine will
help them save money and time, while improving quality of care received.
Over 90% of patients are willing to learn how to use video call applications.
● We identified four potential telemedicine models and key operational
requirements. We recommend having Case Managers to act as a single
point of contact for patients. Necessary infrastructure for the pilot should
include (i) video conferencing capabilities and (ii) secure data protection.
● A 3-year telemedicine pilot program is estimated to bring at least
£6.8M in healthcare cost savings while the project itself will cost
approx. £975k. There is further scope for cost containment through
outsourcing or using cloud storage.
4
The project is structured into four phases,
each containing separate work streams
5
Phase 1
Background research
Phase 2
Establishing
feasibility of
telemedicine pilot
Phase 3
In-depth cost
analysis
Phase 4
Preparing for
consortium bid
• Examine already
established
international
pilots
• Interview KOLs to
understand the
benefits of, and
need for,
telemedicine
• Establish demand
for telemedicine
pilot by creating
and conducting
surveys
• Talk to leaders of
existing services
• Obtain hospital
administration
feedback on how
telemedicine might
affect care
• Develop
infrastructural
model
• Perform in-depth
cost analysis
based on current
models
• Leverage insights
from Phases 1/2 to
develop a cost
model
• Categorise
different funding
sources
• Seek partners
within the CRDN
network
• Ensure participants
develop impact of
pilot together
• Develop an
implementation
plan for launching
pilot study and
scaling up
(UK-wide)
Collectively, rare diseases are not ‘rare’, both
nationally in the UK and regionally in Cambridge
Source: Previous CCN analysis
6
Nationally, there are ~3 million
patients with rare diseases
• A rare disease is a life-threatening or
chronic disease that affects less than
5 people in 10,000
• 1 in 17 people will suffer from a rare
disease
• UK population in 2016 was
~65 million
• In Cambridgeshire, the population is
~800,000
At least 3,000 patients reside in
Cambridge
Rare disease patients are confronted with a range
of challenges
7
Source: RareReality 2016
http://www.raredisease.org.uk/our-work/the-rare-reality-an-insight-into-the-patient-and-family-experience-of-rare-disease-2016/
Telemedicine would impact multiple stakeholders
Patients Hospitals
Families
Healthcare
professionals
Telemedicine affects every facet of the
healthcare system
8
Telemedicine has the potential to generate tangible
benefits for the entire healthcare system
Source: Widespread deployment of telemedicine services in Europe
ec.europa.eu/information_society/newsroom/cf/dae/document.cfm?doc_id=5167
● Provide access to
scarce expertise
● Reduce delays in
correct diagnosis
● Reduce travel costs
and save time
Telemedicine has the power to improve the patient experience significantly
9
Patients Doctors Hospitals
● Provide access to
scarce expertise
● Reduce delays in
correct diagnosis
● Reduce travel costs and
save time
● Reduce absenteeism
and late appointments
● Upskill doctors in
patient’s local area
● Provide holistic patient
care by interacting with
other specialists
● Generate cost savings
● Access to patients to
conduct clinical research
Successful telemedicine pilots in paediatric care in
Queensland, Australia provide award-winning care
The Centre for Online Health has pioneered a
unique way to deal with Queensland’s rural
population
90% of referrals lead
to consultations via
video conference
Over 15,000
consultations have
been conducted
since 2000
37 different
subspecialties of
paediatric care are
offered
Significant savings
for the healthcare
provider and
patients were
generated
Source: University of Queensland. https://www.uq.edu.au/news/article/2011/09/award-winning-telemedicine-trial-sick-infants
10
Scotland has adopted telemedicine programmes
more quickly than other countries
Source: Scottish Centre for Telehealth and Telecare 2016 Report https://sctt.org.uk/sctt-end-year-report/
11
Scottish Centre of
Telehealth & Telecare
Partners
Mastermind is a
computerised cognitive
behaviour therapy for
patients suffering from
mental health problems
United4Health is a
telemonitoring service for
patients with Diabetes,
COPD and Congestive Heart
Failure
SmartCare is in development
to deliver better
coordination and integrated
care with 7 health and care
partnerships
Living It Up is an online
supported,
self-management service for
people with long term health
and care conditions
Survey establishes patient’s demand for a
telemedicine pilot programme
Aims of survey
Determine rare disease
patient preferences and
support for telemedicine
vs
in-person visits
Determine if patients
can easily access a
telemedicine platform to
participate in pilot
12
• Main groups of patients targeted are seen at Addenbrooke’s Lysosomal Disorder Unit (250
patients), Addenbrooke's Severe Insulin Resistance Clinic (150 patients) and Birmingham
Children’s Hospital
(280 patients)
• Disseminated to patients via CRDN and other platforms
Patients
targeted
• Examine the proportion of patients choosing different answers across each questions using pie
charts and bar graphs
• Compare the different segments of patients, based on age of patient and the clinic the patient is
seen at
Methods of
analysis
Percentage of respondents who are willing to
participate in a telemedicine pilot
● Number of respondents: 67
● 60% willing to participate in telemedicine trial (pilot)
13
14
Survey respondents believe that telemedicine will
help them in a variety of ways
Survey respondents portray a positive attitude towards usage of
high-tech devices
15
Necessary components of the pilot pose potential
challenges for setup
Essential
factors for the
pilot
Operational requirements
Legal requirements
16
Proposal:
Regional
Case
Managers
One-stop
shop
service
Single point of
contact for advice,
care and support
PILOT
Centre:
NoRo Centre,
Romania
Target
population:
Patients with
rare diseases
Cases per
manager:
30 (simultaneous)
Time frame:
18 months
(Jan 17–Jun 18)
EURORDIS: European Organisation for Rare Diseases
Source: Interview with Raquel Castro
17
EURORDIS’s InnovCare Project provided insight into
designing a pilot study in Romania
Source: Interview with Raquel Castro
18
The InnovCare project focuses on the role of case managers
as a single point of contact for all patient needs
• Single and stable point of contact: hub of information and knowledge
• Listen, inform, support and empower patients and families, as well as
professionals involved in
care provision
• Facilitating coordination between services and networks of service providers
• Assessment/monitoring of needs, and observing those needs
Role of case
managers
• Centre has existing provisions: physical therapy, speech therapy, training for staff,
information and guidance services, etc.
• Romanian healthcare system has a centralised software for patient files
and data
Existing
infrastructure
Challenges
Administrative
Case Managers considered
“threatening” and
interfering by care
providers -
Important to introduce in
an appropriate way
19
Challenges faced while setting up the Romanian pilot were
centred on obtaining robust technology
Technological
Limited/compromised access
to internet, and insufficient
connection for
teleconferences
Need at least one person to
fix these problems
OrangeHealth – setting up telemedicine projects in France (three regions)
20
Source: Interview with Andrew Green (OrangeHealth)
Telemedicine pilot set up in France suggests companies for
workflow software and teleconferencing software
Infrastructure
● Workflow management
● Cloud-based patient file management
● Access to patient data
● Imaging systems
● Equipment: camera, screens, network connections
Acceois provided the software for telemedicine workflow management
Equatel provided robust teleconference terminals – links with monitoring equipment
Operational requirements will require expansion of
current infrastructure
Operational
requirements for
telemedicine pilot
Working infrastructure:
working computers/tablets
with cameras
Seminar rooms/space for calls
Internet connection
Robust and secure: patient
and specialist
e-Health records
Constant access to the
patients files
Reliable teleconference
software
complies with privacy
regulations around
access to records
Source: CCN interviews with key opinion leaders and Scotland pilot program
21
Legal infrastructure for Romanian pilot was governed
by national regulations
Data protection
and legal
infrastructure
The NoRo centre has social service and healthcare
provider status
Source: Interview with Raquel Castro
Patient files are under the control of the patient:
patient decides, patient shares
22
Telemedicine pilot set up in France by OrangeHealth
focused on the efforts made to comply with data privacy
Source: Interview with Andrew Green (OrangeHealth)
23
Data protection
● OrangeHealth provided virtual private network (VPN)
● OrangeCloud hosted data
Took 2 years to get approval
Issues:
● Full-time doctor availability
● Data duplication/back-up
● Data vulnerability
● Intrusion by external forces
Both comply with
France’s regulations
Both hospitals being considered for the pilot have
governance teams for ensuring data protection
Birmingham Children’s Hospital
Own Information Governance team,
that complies with national data
privacy regulations
Addenbrooke’s Hospital
Own Information Governance team,
ensuring that patient information is
dealt with legally and securely to
appropriate ethical and quality
standards (10 standards and
requirements, including Health Records
Management, Confidentiality and the
Data Protection Act 1998)
24
Impact of data protection and operational requirements
on plans for telemedicine arrangements
DATA PROTECTION
Informed consent of pilot
participants is important
● Main concern during group
calls with consultant
● Patients may be uncomfortable
with exposure to private data
OPERATIONAL REQUIREMENTS
Direct impact on all
arrangements
● Equipment with camera
is crucial
● E-health records must be
available to the doctor in order
to make best medical decisions
25
Telemedicine
arrangement formats
(via video calls)
Patient to specialist
nurse/physician
from patient’s home
Small groups of patients
to specialist doctor
Patient at local GP to
specialist nurse/physician
Patient to specialist
nurse/physician + remote
monitoring of
physiological parameters
Proposed telemedicine arrangements have been
narrowed down to four potential formats
Source: CCN interviews with key opinion leaders
26
Patient at local GP to specialist nurse/physician model
may not get the GP buy-in necessary for success
Source: Interview with Helena Baker (Medical Research Network)
27
1. GP workload prohibits taking on additional responsibility
“The key issue with that model is you don’t get GP buy-in. The GPs are under such huge
pressure, and when a patient has a rare disease, GPs very much want the consultants
to come in and deal with that.”
2. Lack of education buy-in among GPs
“There is a small cohort of GPs interested in continuing education and doing exciting
new novel things like that – the vast majority won’t. But only 5% of GPs take part in
clinical trials anyway.”
3. Logistical difficulty in lining up schedules
Both GPs and consultants already sometimes face issues with scheduling, as clinics they
have with patients sometimes start late. This will pose a significant challenge should
both parties be involved in a given consultation.
A 3-year telemedicine pilot programme in Cambridgeshire is
likely to save £34 million by improving healthcare outcomes
Source: WDS Headline Findings & The King’s Fund Publications.
https://www.kingsfund.org.uk/publications/articles/kent-telehealth-pilot-study
28
Case study in Kent
• As indicated in the
pilot study, telemedicine
could reduce clinician
home visits, unplanned
admissions and
A&E visits
• The 6-month pilot study
has led to an average
saving of £1,878 per
patient
Extrapolating to Cambridgeshire
• A 3-year pilot programme in
Cambridgeshire is therefore likely to
save £1,878 x 6 = £11,268 per patient
• Assuming 3,000 patients with rare
diseases live in Cambridgeshire, the
aggregate saving would be £34 million,
plus improved health care outcomes
• These figures further highlight
the effectiveness of telemedicine
in cost-savings
Cost difference for each telemedicine meeting vs. in-person visit
• Assume average travel costs around Cambridgeshire is £20
for a round trip
• Assume each visit consumes 1 hour on the road and costs
£44 for nurse hourly wage (not directly patient-related work)
Compared to in-person visits by nurses, the use of a
telemedicine platform could further save £44 costs per meeting
Source: Unit Costs of Health and Social Care 2015; http://www.pssru.ac.uk/project-pages/unit-costs/2015/
Saving on
travel-related costs:
£64
Extra cost for
telemedicine platform:
£20
Each telemedicine meeting could save £64 - £20 = £44
• Market research indicates that telemedicine platforms (e.g. 1
Doc Way in the U.S.) cost c.£20/hour
• Assume each telemedicine meeting lasts at most 1 hour
29
30
To construct a cost model for the pilot program, patient
segmentation is performed on Addenbrooke’s and BCH, followed
by fixed and variable cost projection
Variable
costs
Fixed
costs
Equipment
Overhead: Admin & IT staff
Training
Attributable nurse salary
Additional data storage
System maintenance and upgrade
Installation
Travel (reserve level)
Addenbrooke's Hospital (N=650)
● Lysosomal/Metabolic Disorder Unit (500)
● Severe Insulin Resistance Unit (150)
Birmingham Children’s Hospital (N=280)
● Autosomal Recessive Polycystic Kidney
Diseases (80)
● Cystic Fibrosis (100)
● Tumour Suppressor Complex (100)
Key assumptions
● UK internet access rate: 92%
● Initial adoption rate: 70%
● Annual dropout rate: 5%
● Additional buffer time for system handling: 15%
● Patient terminal: £405
● Hospital terminal: £6,098
Source: World Bank, Frost & Sullivan, Unit Costs of Health and Social Care 2013 & 2015; http://www.pssru.ac.uk/project-pages/unit-costs/2015/
Total cost of the 3-year pilot program is estimated at £975K, with
equipment costs and specialist nurse salaries being major cost drivers,
contributing to 31% and 28% of total cost, respectively
% of
total
31% 3% 4% 21% 28% 5% 5% 3% 100%
• Given the high requirement of upfront infrastructure investment, fixed costs account for 59% of total costs
• This further supports the idea of leveraging existing hardware resources, or procuring less customized
telemedicine solutions as long as the healthcare effectiveness is not compromised
31
Splitting costs along a timeline, initial setup costs take up 36% of
total costs, with the remaining costs evenly distributed throughout the
3-year pilot program period
• 61% of fixed costs will be incurred in the initial setup phase
• This indicates the possibility to achieve greater economies of scale (i.e. lower costs on a per
meeting basis) when the pilot program is extended to a longer period
• CRDN may opt for applying to additional grants or forming partnerships to finance a longer
program
32
For cost containment, besides equipment procurement, overhead and data
storage costs could further be reduced if IT and admin staff are outsourced
and cloud storage is used
Cost model summary for the 3-year telemedicine pilot program:
Source (model assumptions): World Bank, Office for National Statistics, Orange Health, Cambridge Consultants, Unit Costs of Health and Social Care
2013 & 2015; http://www.pssru.ac.uk/project-pages/unit-costs/2015/
33
Potential benefits of the pilot program is projected to be £6.8M
The telemedicine pilot program is estimated to bring 6.0x return on
investments and thus represents strong financial saving potential
• Extrapolating the cost-saving experience from Kent, a 3-year pilot study could lead to
an average financial saving of £11,268 per patient
• In the cost model, there would be 604 patients on average using the telemedicine
platform throughout the program horizon
• Therefore, the estimated benefits could amount to £11,268 X 604 =£6.80M
34
Estimated ROI = (£6.80M - £0.98M)/£0.98M = 6.0x
Cost difference for each telemedicine meeting vs. in-person visit
• Assume average travel costs around Cambridgeshire is £20
for a round trip
• Assume each visit consumes 1 hour on the road and costs
£44 for nurse hourly wage (not directly patient-related work)
Compared to in-person visits by nurses, the use of a
telemedicine platform could further save £44 costs per meeting
Source: Unit Costs of Health and Social Care 2015; http://www.pssru.ac.uk/project-pages/unit-costs/2015/
Saving on
travel-related costs:
£64
Extra cost for
telemedicine platform:
£20
Each telemedicine meeting could save £64 - £20 = £44
• Market research indicates that telemedicine platforms (e.g. 1
Doc Way in the U.S.) cost c.£20/hour
• Assume each telemedicine meeting lasts at most 1 hour
35
Executive Summary
● There is strong demand for a telemedicine pilot program from rare
disease patients. Our survey findings indicates that a majority of patients
are receptive to a telemedicine pilot -- over 50% believe telemedicine will
help them save money and time, while improving quality of care received.
Over 90% of patients are willing to learn how to use video call applications.
● We identified four potential telemedicine models and key operational
requirements. We recommend having Case Managers to act as a single
point of contact for patients. Necessary infrastructure for the pilot should
include (i) video conferencing capabilities and (ii) secure data protection.
● A 3-year telemedicine pilot program is estimated to bring at least
£6.8M in healthcare cost savings while the project itself will cost
approx. £975k. There is further scope for cost containment through
outsourcing or using cloud storage.
36
‘This work has been undertaken as part of a student educational project and the material should be
viewed in this context. The work does not constitute professional advice and no warranties are made
regarding the information presented. Cambridge Consulting Network do not accept any liability for the
consequences of any action taken as a result of the work or any recommendations made or inferred’
Thank you
Natalie Rebeyev: nr406am.ac.uk
Saakshi Chadha: sc885@cam.ac.uk
37

More Related Content

What's hot

Is there patient involvement in HTA? Can patients influence HTA decision making?
Is there patient involvement in HTA? Can patients influence HTA decision making?Is there patient involvement in HTA? Can patients influence HTA decision making?
Is there patient involvement in HTA? Can patients influence HTA decision making?
Kathi Apostolidis
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
jangeissler
 
WHITE PAPER: What’s Next in US Payor Communications: The Impact of FDA's Prop...
WHITE PAPER: What’s Next in US Payor Communications: The Impact of FDA's Prop...WHITE PAPER: What’s Next in US Payor Communications: The Impact of FDA's Prop...
WHITE PAPER: What’s Next in US Payor Communications: The Impact of FDA's Prop...
Nathan White, CPC
 
Consumer involvement: Patient views on participation in HTA
Consumer involvement: Patient views on participation in HTAConsumer involvement: Patient views on participation in HTA
Consumer involvement: Patient views on participation in HTA
Cochrane.Collaboration
 
Canada’s Orphan Drug Regulatory Framework: What Health Canada is doing now an...
Canada’s Orphan Drug Regulatory Framework: What Health Canada is doing now an...Canada’s Orphan Drug Regulatory Framework: What Health Canada is doing now an...
Canada’s Orphan Drug Regulatory Framework: What Health Canada is doing now an...
Canadian Organization for Rare Disorders
 
What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...
What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...
What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...
Nathan White, CPC
 
0201a pemberton w how to create evidence for advocacy impact 1.1
0201a pemberton w   how to create evidence for advocacy impact 1.10201a pemberton w   how to create evidence for advocacy impact 1.1
0201a pemberton w how to create evidence for advocacy impact 1.1
Workgroup of European Cancer Patient Advocacy Networks
 
0401 2 Ananda Plate - Patient Preferences
0401 2 Ananda Plate - Patient Preferences0401 2 Ananda Plate - Patient Preferences
0401 2 Ananda Plate - Patient Preferences
Workgroup of European Cancer Patient Advocacy Networks
 
Richard Scott - Cambridge Rare Disease Summit 2015
Richard Scott - Cambridge Rare Disease Summit 2015Richard Scott - Cambridge Rare Disease Summit 2015
Richard Scott - Cambridge Rare Disease Summit 2015
CamRARE Disease Network
 
Pharmacare - Caveat Emptor (Let the Buyer Beware)
Pharmacare - Caveat Emptor (Let the Buyer Beware)Pharmacare - Caveat Emptor (Let the Buyer Beware)
Pharmacare - Caveat Emptor (Let the Buyer Beware)
Canadian Cancer Survivor Network
 
Canada Market Access Briefing
Canada Market Access BriefingCanada Market Access Briefing
Canada Market Access BriefingMichael Jacobson
 
Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview
Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview
Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview
Canadian Organization for Rare Disorders
 
Himss m healthcomm_telehealth md exec summary recommendations_formatted final...
Himss m healthcomm_telehealth md exec summary recommendations_formatted final...Himss m healthcomm_telehealth md exec summary recommendations_formatted final...
Himss m healthcomm_telehealth md exec summary recommendations_formatted final...
mHealth2015
 
Patient Engagement in Drug Review: Helen Mai (CADTH)
Patient Engagement in Drug Review: Helen Mai (CADTH)Patient Engagement in Drug Review: Helen Mai (CADTH)
Patient Engagement in Drug Review: Helen Mai (CADTH)
Canadian Organization for Rare Disorders
 
Patient Group Development and Engagement
Patient Group Development and EngagementPatient Group Development and Engagement
Patient Group Development and Engagement
Canadian Organization for Rare Disorders
 
Analysis of EU – Brazil cooperation opportunities on teleHealth
Analysis of EU – Brazil cooperation opportunities on teleHealthAnalysis of EU – Brazil cooperation opportunities on teleHealth
Analysis of EU – Brazil cooperation opportunities on teleHealth
Universitat Politècnica de València
 
Steffen Thirstrup - Patient involvement when, why, who?
Steffen Thirstrup - Patient involvement when, why, who?Steffen Thirstrup - Patient involvement when, why, who?
Steffen Thirstrup - Patient involvement when, why, who?
koradk
 
Amplifying the High-Touch of Specialty Pharmacy through Mobile and Web-Based ...
Amplifying the High-Touch of Specialty Pharmacy through Mobile and Web-Based ...Amplifying the High-Touch of Specialty Pharmacy through Mobile and Web-Based ...
Amplifying the High-Touch of Specialty Pharmacy through Mobile and Web-Based ...
Avella Specialty Pharmacy
 
STREAM THREE: Jeff Keefer, Inclusion in Clinical Trials
STREAM THREE: Jeff Keefer, Inclusion in Clinical Trials STREAM THREE: Jeff Keefer, Inclusion in Clinical Trials
STREAM THREE: Jeff Keefer, Inclusion in Clinical Trials
Canadian Organization for Rare Disorders
 
Pan-Canadian Pharmaceutical Alliance – a Primer June 22, 2016 Webinar Slides
Pan-Canadian Pharmaceutical Alliance – a Primer June 22, 2016 Webinar SlidesPan-Canadian Pharmaceutical Alliance – a Primer June 22, 2016 Webinar Slides
Pan-Canadian Pharmaceutical Alliance – a Primer June 22, 2016 Webinar Slides
Canadian Organization for Rare Disorders
 

What's hot (20)

Is there patient involvement in HTA? Can patients influence HTA decision making?
Is there patient involvement in HTA? Can patients influence HTA decision making?Is there patient involvement in HTA? Can patients influence HTA decision making?
Is there patient involvement in HTA? Can patients influence HTA decision making?
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
 
WHITE PAPER: What’s Next in US Payor Communications: The Impact of FDA's Prop...
WHITE PAPER: What’s Next in US Payor Communications: The Impact of FDA's Prop...WHITE PAPER: What’s Next in US Payor Communications: The Impact of FDA's Prop...
WHITE PAPER: What’s Next in US Payor Communications: The Impact of FDA's Prop...
 
Consumer involvement: Patient views on participation in HTA
Consumer involvement: Patient views on participation in HTAConsumer involvement: Patient views on participation in HTA
Consumer involvement: Patient views on participation in HTA
 
Canada’s Orphan Drug Regulatory Framework: What Health Canada is doing now an...
Canada’s Orphan Drug Regulatory Framework: What Health Canada is doing now an...Canada’s Orphan Drug Regulatory Framework: What Health Canada is doing now an...
Canada’s Orphan Drug Regulatory Framework: What Health Canada is doing now an...
 
What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...
What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...
What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...
 
0201a pemberton w how to create evidence for advocacy impact 1.1
0201a pemberton w   how to create evidence for advocacy impact 1.10201a pemberton w   how to create evidence for advocacy impact 1.1
0201a pemberton w how to create evidence for advocacy impact 1.1
 
0401 2 Ananda Plate - Patient Preferences
0401 2 Ananda Plate - Patient Preferences0401 2 Ananda Plate - Patient Preferences
0401 2 Ananda Plate - Patient Preferences
 
Richard Scott - Cambridge Rare Disease Summit 2015
Richard Scott - Cambridge Rare Disease Summit 2015Richard Scott - Cambridge Rare Disease Summit 2015
Richard Scott - Cambridge Rare Disease Summit 2015
 
Pharmacare - Caveat Emptor (Let the Buyer Beware)
Pharmacare - Caveat Emptor (Let the Buyer Beware)Pharmacare - Caveat Emptor (Let the Buyer Beware)
Pharmacare - Caveat Emptor (Let the Buyer Beware)
 
Canada Market Access Briefing
Canada Market Access BriefingCanada Market Access Briefing
Canada Market Access Briefing
 
Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview
Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview
Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview
 
Himss m healthcomm_telehealth md exec summary recommendations_formatted final...
Himss m healthcomm_telehealth md exec summary recommendations_formatted final...Himss m healthcomm_telehealth md exec summary recommendations_formatted final...
Himss m healthcomm_telehealth md exec summary recommendations_formatted final...
 
Patient Engagement in Drug Review: Helen Mai (CADTH)
Patient Engagement in Drug Review: Helen Mai (CADTH)Patient Engagement in Drug Review: Helen Mai (CADTH)
Patient Engagement in Drug Review: Helen Mai (CADTH)
 
Patient Group Development and Engagement
Patient Group Development and EngagementPatient Group Development and Engagement
Patient Group Development and Engagement
 
Analysis of EU – Brazil cooperation opportunities on teleHealth
Analysis of EU – Brazil cooperation opportunities on teleHealthAnalysis of EU – Brazil cooperation opportunities on teleHealth
Analysis of EU – Brazil cooperation opportunities on teleHealth
 
Steffen Thirstrup - Patient involvement when, why, who?
Steffen Thirstrup - Patient involvement when, why, who?Steffen Thirstrup - Patient involvement when, why, who?
Steffen Thirstrup - Patient involvement when, why, who?
 
Amplifying the High-Touch of Specialty Pharmacy through Mobile and Web-Based ...
Amplifying the High-Touch of Specialty Pharmacy through Mobile and Web-Based ...Amplifying the High-Touch of Specialty Pharmacy through Mobile and Web-Based ...
Amplifying the High-Touch of Specialty Pharmacy through Mobile and Web-Based ...
 
STREAM THREE: Jeff Keefer, Inclusion in Clinical Trials
STREAM THREE: Jeff Keefer, Inclusion in Clinical Trials STREAM THREE: Jeff Keefer, Inclusion in Clinical Trials
STREAM THREE: Jeff Keefer, Inclusion in Clinical Trials
 
Pan-Canadian Pharmaceutical Alliance – a Primer June 22, 2016 Webinar Slides
Pan-Canadian Pharmaceutical Alliance – a Primer June 22, 2016 Webinar SlidesPan-Canadian Pharmaceutical Alliance – a Primer June 22, 2016 Webinar Slides
Pan-Canadian Pharmaceutical Alliance – a Primer June 22, 2016 Webinar Slides
 

Similar to Natalie Rebeyev rare disease nurse network crdn summit 2017

Telemedicine in Skilled Nursing Facilities by Reza Sadeghian
Telemedicine in Skilled Nursing  Facilities by Reza SadeghianTelemedicine in Skilled Nursing  Facilities by Reza Sadeghian
Telemedicine in Skilled Nursing Facilities by Reza Sadeghian
Reza Sadeghian
 
Patient in the digital world
Patient in the digital worldPatient in the digital world
Patient in the digital world
PwC Polska
 
Informatics And Telehealth In Rural Medicines TedEx Video Analysis.pdf
Informatics And Telehealth In Rural Medicines TedEx Video Analysis.pdfInformatics And Telehealth In Rural Medicines TedEx Video Analysis.pdf
Informatics And Telehealth In Rural Medicines TedEx Video Analysis.pdf
bkbk37
 
eHealth as a tool to support health practitioners November 2013
eHealth as a tool to support health practitioners November 2013eHealth as a tool to support health practitioners November 2013
eHealth as a tool to support health practitioners November 2013
Rajeev Rao Eashwari
 
Telecommunication systems applied to telemedicine
Telecommunication systems applied to telemedicineTelecommunication systems applied to telemedicine
Telecommunication systems applied to telemedicine
Shazia Iqbal
 
Process Automation in Telemedicine - The Italian Perspective
Process Automation in Telemedicine - The Italian PerspectiveProcess Automation in Telemedicine - The Italian Perspective
Process Automation in Telemedicine - The Italian Perspective
Denis Gagné
 
NIHR partnering with industry
NIHR partnering with industryNIHR partnering with industry
NIHR partnering with industry
Health and Care Innovation Expo
 
Medical assistance of remote patients through telemedicine benefits and probl...
Medical assistance of remote patients through telemedicine benefits and probl...Medical assistance of remote patients through telemedicine benefits and probl...
Medical assistance of remote patients through telemedicine benefits and probl...
Shazia Iqbal
 
The Concept of Application of Telemedicine in Indonesia
The Concept of Application of Telemedicine in IndonesiaThe Concept of Application of Telemedicine in Indonesia
The Concept of Application of Telemedicine in Indonesia
Hamedoemar
 
The Expanding World of Telehealth
The Expanding World of TelehealthThe Expanding World of Telehealth
The Expanding World of Telehealth
IVCi, LLC
 
Telemedicine and its application in public health
Telemedicine and its application in public healthTelemedicine and its application in public health
Telemedicine and its application in public health
Dr.Preeti Tiwari
 
Overcoming Fear of Health Technology Programs
Overcoming Fear of Health Technology ProgramsOvercoming Fear of Health Technology Programs
Overcoming Fear of Health Technology Programs
bartlettc
 
Telehealth Remote Monitoring and Diagnostics
Telehealth Remote Monitoring and DiagnosticsTelehealth Remote Monitoring and Diagnostics
Telehealth Remote Monitoring and Diagnostics
Ammar
 
Tele-Cardiology Services in the UK - Telehealth Magazine (April 2008)
Tele-Cardiology Services in the UK - Telehealth Magazine (April 2008)Tele-Cardiology Services in the UK - Telehealth Magazine (April 2008)
Tele-Cardiology Services in the UK - Telehealth Magazine (April 2008)Ofer Atzmon
 
Presenter Slides - Matthew Ginn, Proximie
Presenter Slides - Matthew Ginn, ProximiePresenter Slides - Matthew Ginn, Proximie
Presenter Slides - Matthew Ginn, Proximie
Health Innovation Wessex
 
Telenephrology
TelenephrologyTelenephrology
Telenephrology
Christos Argyropoulos
 
Connected Health Progress Report
Connected Health Progress ReportConnected Health Progress Report
Connected Health Progress Report
Health Informatics New Zealand
 
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...
PharmaLedger
 
Babithas Notes on unit-5 Health/Nursing Informatics Technology
Babithas Notes on unit-5 Health/Nursing Informatics TechnologyBabithas Notes on unit-5 Health/Nursing Informatics Technology
Babithas Notes on unit-5 Health/Nursing Informatics Technology
Babitha Devu
 

Similar to Natalie Rebeyev rare disease nurse network crdn summit 2017 (20)

Telemedicine in Skilled Nursing Facilities by Reza Sadeghian
Telemedicine in Skilled Nursing  Facilities by Reza SadeghianTelemedicine in Skilled Nursing  Facilities by Reza Sadeghian
Telemedicine in Skilled Nursing Facilities by Reza Sadeghian
 
Patient in the digital world
Patient in the digital worldPatient in the digital world
Patient in the digital world
 
Informatics And Telehealth In Rural Medicines TedEx Video Analysis.pdf
Informatics And Telehealth In Rural Medicines TedEx Video Analysis.pdfInformatics And Telehealth In Rural Medicines TedEx Video Analysis.pdf
Informatics And Telehealth In Rural Medicines TedEx Video Analysis.pdf
 
eHealth as a tool to support health practitioners November 2013
eHealth as a tool to support health practitioners November 2013eHealth as a tool to support health practitioners November 2013
eHealth as a tool to support health practitioners November 2013
 
Telecommunication systems applied to telemedicine
Telecommunication systems applied to telemedicineTelecommunication systems applied to telemedicine
Telecommunication systems applied to telemedicine
 
Process Automation in Telemedicine - The Italian Perspective
Process Automation in Telemedicine - The Italian PerspectiveProcess Automation in Telemedicine - The Italian Perspective
Process Automation in Telemedicine - The Italian Perspective
 
NIHR partnering with industry
NIHR partnering with industryNIHR partnering with industry
NIHR partnering with industry
 
Medical assistance of remote patients through telemedicine benefits and probl...
Medical assistance of remote patients through telemedicine benefits and probl...Medical assistance of remote patients through telemedicine benefits and probl...
Medical assistance of remote patients through telemedicine benefits and probl...
 
The Concept of Application of Telemedicine in Indonesia
The Concept of Application of Telemedicine in IndonesiaThe Concept of Application of Telemedicine in Indonesia
The Concept of Application of Telemedicine in Indonesia
 
The Expanding World of Telehealth
The Expanding World of TelehealthThe Expanding World of Telehealth
The Expanding World of Telehealth
 
Telemedicine and its application in public health
Telemedicine and its application in public healthTelemedicine and its application in public health
Telemedicine and its application in public health
 
Overcoming Fear of Health Technology Programs
Overcoming Fear of Health Technology ProgramsOvercoming Fear of Health Technology Programs
Overcoming Fear of Health Technology Programs
 
Connected health venfinal
Connected health venfinalConnected health venfinal
Connected health venfinal
 
Telehealth Remote Monitoring and Diagnostics
Telehealth Remote Monitoring and DiagnosticsTelehealth Remote Monitoring and Diagnostics
Telehealth Remote Monitoring and Diagnostics
 
Tele-Cardiology Services in the UK - Telehealth Magazine (April 2008)
Tele-Cardiology Services in the UK - Telehealth Magazine (April 2008)Tele-Cardiology Services in the UK - Telehealth Magazine (April 2008)
Tele-Cardiology Services in the UK - Telehealth Magazine (April 2008)
 
Presenter Slides - Matthew Ginn, Proximie
Presenter Slides - Matthew Ginn, ProximiePresenter Slides - Matthew Ginn, Proximie
Presenter Slides - Matthew Ginn, Proximie
 
Telenephrology
TelenephrologyTelenephrology
Telenephrology
 
Connected Health Progress Report
Connected Health Progress ReportConnected Health Progress Report
Connected Health Progress Report
 
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...
 
Babithas Notes on unit-5 Health/Nursing Informatics Technology
Babithas Notes on unit-5 Health/Nursing Informatics TechnologyBabithas Notes on unit-5 Health/Nursing Informatics Technology
Babithas Notes on unit-5 Health/Nursing Informatics Technology
 

More from CamRARE Disease Network

RS23_WelcomeAddress_CamRARE Highlights 2019 - 2023.pptx
RS23_WelcomeAddress_CamRARE Highlights 2019 - 2023.pptxRS23_WelcomeAddress_CamRARE Highlights 2019 - 2023.pptx
RS23_WelcomeAddress_CamRARE Highlights 2019 - 2023.pptx
CamRARE Disease Network
 
Tonia Hymers bardet biedl syndrome uk crdn summit 2017
Tonia Hymers bardet biedl syndrome uk crdn summit 2017Tonia Hymers bardet biedl syndrome uk crdn summit 2017
Tonia Hymers bardet biedl syndrome uk crdn summit 2017
CamRARE Disease Network
 
Sue Routledge pitt hopkins syndrome uk crdn summit 2017
Sue Routledge pitt hopkins syndrome uk crdn summit 2017Sue Routledge pitt hopkins syndrome uk crdn summit 2017
Sue Routledge pitt hopkins syndrome uk crdn summit 2017
CamRARE Disease Network
 
Simon holden red flags rare disease crdn summit 2017
Simon holden red flags rare disease crdn summit 2017Simon holden red flags rare disease crdn summit 2017
Simon holden red flags rare disease crdn summit 2017
CamRARE Disease Network
 
Rick Thompson findacure crdn summit 2017
Rick Thompson findacure crdn summit 2017Rick Thompson findacure crdn summit 2017
Rick Thompson findacure crdn summit 2017
CamRARE Disease Network
 
Owen Vaughan prometics crdn summit 2017
Owen Vaughan prometics crdn summit 2017Owen Vaughan prometics crdn summit 2017
Owen Vaughan prometics crdn summit 2017
CamRARE Disease Network
 
Neil Dugdale sobi crdn summit 2017
Neil Dugdale sobi crdn summit 2017Neil Dugdale sobi crdn summit 2017
Neil Dugdale sobi crdn summit 2017
CamRARE Disease Network
 
Mabella Farrer addenbrookes crdn summit 2017
Mabella Farrer addenbrookes crdn summit 2017Mabella Farrer addenbrookes crdn summit 2017
Mabella Farrer addenbrookes crdn summit 2017
CamRARE Disease Network
 
Lynn Laidlaw and Suzanne morris vasculitis uk crdn summit 2017
Lynn Laidlaw and Suzanne morris vasculitis uk crdn summit 2017Lynn Laidlaw and Suzanne morris vasculitis uk crdn summit 2017
Lynn Laidlaw and Suzanne morris vasculitis uk crdn summit 2017
CamRARE Disease Network
 
Kay parkinson crdn summit 2017
Kay parkinson crdn summit 2017Kay parkinson crdn summit 2017
Kay parkinson crdn summit 2017
CamRARE Disease Network
 
Ignacio Medrano Mendelian crdn summit 2017
Ignacio Medrano Mendelian crdn summit 2017Ignacio Medrano Mendelian crdn summit 2017
Ignacio Medrano Mendelian crdn summit 2017
CamRARE Disease Network
 
Gemma chandratillake crdn crdn summit 2017
Gemma chandratillake crdn crdn summit 2017Gemma chandratillake crdn crdn summit 2017
Gemma chandratillake crdn crdn summit 2017
CamRARE Disease Network
 
Dan Jeffries me myself and eye crdn summit 2017
Dan Jeffries me myself and eye crdn summit 2017Dan Jeffries me myself and eye crdn summit 2017
Dan Jeffries me myself and eye crdn summit 2017
CamRARE Disease Network
 
Ana Mingorance crdn summit 2017
Ana Mingorance crdn summit 2017Ana Mingorance crdn summit 2017
Ana Mingorance crdn summit 2017
CamRARE Disease Network
 
Daniel lewi cats foundation crdn summit 2017
 Daniel lewi cats foundation crdn summit 2017 Daniel lewi cats foundation crdn summit 2017
Daniel lewi cats foundation crdn summit 2017
CamRARE Disease Network
 
The cats foundation power voices dan lewi - crdn summit 2016
The cats foundation power voices dan lewi - crdn summit 2016The cats foundation power voices dan lewi - crdn summit 2016
The cats foundation power voices dan lewi - crdn summit 2016
CamRARE Disease Network
 
Rare revolution the voice of rare crdn summit 2016
Rare revolution the voice of rare crdn summit 2016Rare revolution the voice of rare crdn summit 2016
Rare revolution the voice of rare crdn summit 2016
CamRARE Disease Network
 
Lucy mc kay crdn 2016
Lucy mc kay crdn 2016Lucy mc kay crdn 2016
Lucy mc kay crdn 2016
CamRARE Disease Network
 
Horizon discovery crdn summit 2016
Horizon discovery crdn summit 2016Horizon discovery crdn summit 2016
Horizon discovery crdn summit 2016
CamRARE Disease Network
 
Frambu Norway presentation for crdn summit 2016
Frambu Norway presentation for crdn summit 2016Frambu Norway presentation for crdn summit 2016
Frambu Norway presentation for crdn summit 2016
CamRARE Disease Network
 

More from CamRARE Disease Network (20)

RS23_WelcomeAddress_CamRARE Highlights 2019 - 2023.pptx
RS23_WelcomeAddress_CamRARE Highlights 2019 - 2023.pptxRS23_WelcomeAddress_CamRARE Highlights 2019 - 2023.pptx
RS23_WelcomeAddress_CamRARE Highlights 2019 - 2023.pptx
 
Tonia Hymers bardet biedl syndrome uk crdn summit 2017
Tonia Hymers bardet biedl syndrome uk crdn summit 2017Tonia Hymers bardet biedl syndrome uk crdn summit 2017
Tonia Hymers bardet biedl syndrome uk crdn summit 2017
 
Sue Routledge pitt hopkins syndrome uk crdn summit 2017
Sue Routledge pitt hopkins syndrome uk crdn summit 2017Sue Routledge pitt hopkins syndrome uk crdn summit 2017
Sue Routledge pitt hopkins syndrome uk crdn summit 2017
 
Simon holden red flags rare disease crdn summit 2017
Simon holden red flags rare disease crdn summit 2017Simon holden red flags rare disease crdn summit 2017
Simon holden red flags rare disease crdn summit 2017
 
Rick Thompson findacure crdn summit 2017
Rick Thompson findacure crdn summit 2017Rick Thompson findacure crdn summit 2017
Rick Thompson findacure crdn summit 2017
 
Owen Vaughan prometics crdn summit 2017
Owen Vaughan prometics crdn summit 2017Owen Vaughan prometics crdn summit 2017
Owen Vaughan prometics crdn summit 2017
 
Neil Dugdale sobi crdn summit 2017
Neil Dugdale sobi crdn summit 2017Neil Dugdale sobi crdn summit 2017
Neil Dugdale sobi crdn summit 2017
 
Mabella Farrer addenbrookes crdn summit 2017
Mabella Farrer addenbrookes crdn summit 2017Mabella Farrer addenbrookes crdn summit 2017
Mabella Farrer addenbrookes crdn summit 2017
 
Lynn Laidlaw and Suzanne morris vasculitis uk crdn summit 2017
Lynn Laidlaw and Suzanne morris vasculitis uk crdn summit 2017Lynn Laidlaw and Suzanne morris vasculitis uk crdn summit 2017
Lynn Laidlaw and Suzanne morris vasculitis uk crdn summit 2017
 
Kay parkinson crdn summit 2017
Kay parkinson crdn summit 2017Kay parkinson crdn summit 2017
Kay parkinson crdn summit 2017
 
Ignacio Medrano Mendelian crdn summit 2017
Ignacio Medrano Mendelian crdn summit 2017Ignacio Medrano Mendelian crdn summit 2017
Ignacio Medrano Mendelian crdn summit 2017
 
Gemma chandratillake crdn crdn summit 2017
Gemma chandratillake crdn crdn summit 2017Gemma chandratillake crdn crdn summit 2017
Gemma chandratillake crdn crdn summit 2017
 
Dan Jeffries me myself and eye crdn summit 2017
Dan Jeffries me myself and eye crdn summit 2017Dan Jeffries me myself and eye crdn summit 2017
Dan Jeffries me myself and eye crdn summit 2017
 
Ana Mingorance crdn summit 2017
Ana Mingorance crdn summit 2017Ana Mingorance crdn summit 2017
Ana Mingorance crdn summit 2017
 
Daniel lewi cats foundation crdn summit 2017
 Daniel lewi cats foundation crdn summit 2017 Daniel lewi cats foundation crdn summit 2017
Daniel lewi cats foundation crdn summit 2017
 
The cats foundation power voices dan lewi - crdn summit 2016
The cats foundation power voices dan lewi - crdn summit 2016The cats foundation power voices dan lewi - crdn summit 2016
The cats foundation power voices dan lewi - crdn summit 2016
 
Rare revolution the voice of rare crdn summit 2016
Rare revolution the voice of rare crdn summit 2016Rare revolution the voice of rare crdn summit 2016
Rare revolution the voice of rare crdn summit 2016
 
Lucy mc kay crdn 2016
Lucy mc kay crdn 2016Lucy mc kay crdn 2016
Lucy mc kay crdn 2016
 
Horizon discovery crdn summit 2016
Horizon discovery crdn summit 2016Horizon discovery crdn summit 2016
Horizon discovery crdn summit 2016
 
Frambu Norway presentation for crdn summit 2016
Frambu Norway presentation for crdn summit 2016Frambu Norway presentation for crdn summit 2016
Frambu Norway presentation for crdn summit 2016
 

Recently uploaded

micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 

Recently uploaded (20)

micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 

Natalie Rebeyev rare disease nurse network crdn summit 2017

  • 1. Is there a need for a Rare Disease Nurse Network for patients with rare diseases?
  • 2. The Team Natalie Rebeyev Engagement Manager Chun Hui Lien Senior Consultant Cason Chan Consultant Vidit Doshi Consultant Hanyuying (Sherry) Wang Consultant Saakshi Chadha Consultant 2
  • 3. 1 Demand for a telemedicine pilot program Operational requirements of a telemedicine pilot Cost of a potential telemedicine pilot program3 4 Rare Disease Nurse Network 1 Content 2 3
  • 4. Executive Summary ● There is strong demand for a telemedicine pilot program from rare disease patients. Our survey findings indicates that a majority of patients are receptive to a telemedicine pilot -- over 50% believe telemedicine will help them save money and time, while improving quality of care received. Over 90% of patients are willing to learn how to use video call applications. ● We identified four potential telemedicine models and key operational requirements. We recommend having Case Managers to act as a single point of contact for patients. Necessary infrastructure for the pilot should include (i) video conferencing capabilities and (ii) secure data protection. ● A 3-year telemedicine pilot program is estimated to bring at least £6.8M in healthcare cost savings while the project itself will cost approx. £975k. There is further scope for cost containment through outsourcing or using cloud storage. 4
  • 5. The project is structured into four phases, each containing separate work streams 5 Phase 1 Background research Phase 2 Establishing feasibility of telemedicine pilot Phase 3 In-depth cost analysis Phase 4 Preparing for consortium bid • Examine already established international pilots • Interview KOLs to understand the benefits of, and need for, telemedicine • Establish demand for telemedicine pilot by creating and conducting surveys • Talk to leaders of existing services • Obtain hospital administration feedback on how telemedicine might affect care • Develop infrastructural model • Perform in-depth cost analysis based on current models • Leverage insights from Phases 1/2 to develop a cost model • Categorise different funding sources • Seek partners within the CRDN network • Ensure participants develop impact of pilot together • Develop an implementation plan for launching pilot study and scaling up (UK-wide)
  • 6. Collectively, rare diseases are not ‘rare’, both nationally in the UK and regionally in Cambridge Source: Previous CCN analysis 6 Nationally, there are ~3 million patients with rare diseases • A rare disease is a life-threatening or chronic disease that affects less than 5 people in 10,000 • 1 in 17 people will suffer from a rare disease • UK population in 2016 was ~65 million • In Cambridgeshire, the population is ~800,000 At least 3,000 patients reside in Cambridge
  • 7. Rare disease patients are confronted with a range of challenges 7 Source: RareReality 2016 http://www.raredisease.org.uk/our-work/the-rare-reality-an-insight-into-the-patient-and-family-experience-of-rare-disease-2016/
  • 8. Telemedicine would impact multiple stakeholders Patients Hospitals Families Healthcare professionals Telemedicine affects every facet of the healthcare system 8
  • 9. Telemedicine has the potential to generate tangible benefits for the entire healthcare system Source: Widespread deployment of telemedicine services in Europe ec.europa.eu/information_society/newsroom/cf/dae/document.cfm?doc_id=5167 ● Provide access to scarce expertise ● Reduce delays in correct diagnosis ● Reduce travel costs and save time Telemedicine has the power to improve the patient experience significantly 9 Patients Doctors Hospitals ● Provide access to scarce expertise ● Reduce delays in correct diagnosis ● Reduce travel costs and save time ● Reduce absenteeism and late appointments ● Upskill doctors in patient’s local area ● Provide holistic patient care by interacting with other specialists ● Generate cost savings ● Access to patients to conduct clinical research
  • 10. Successful telemedicine pilots in paediatric care in Queensland, Australia provide award-winning care The Centre for Online Health has pioneered a unique way to deal with Queensland’s rural population 90% of referrals lead to consultations via video conference Over 15,000 consultations have been conducted since 2000 37 different subspecialties of paediatric care are offered Significant savings for the healthcare provider and patients were generated Source: University of Queensland. https://www.uq.edu.au/news/article/2011/09/award-winning-telemedicine-trial-sick-infants 10
  • 11. Scotland has adopted telemedicine programmes more quickly than other countries Source: Scottish Centre for Telehealth and Telecare 2016 Report https://sctt.org.uk/sctt-end-year-report/ 11 Scottish Centre of Telehealth & Telecare Partners Mastermind is a computerised cognitive behaviour therapy for patients suffering from mental health problems United4Health is a telemonitoring service for patients with Diabetes, COPD and Congestive Heart Failure SmartCare is in development to deliver better coordination and integrated care with 7 health and care partnerships Living It Up is an online supported, self-management service for people with long term health and care conditions
  • 12. Survey establishes patient’s demand for a telemedicine pilot programme Aims of survey Determine rare disease patient preferences and support for telemedicine vs in-person visits Determine if patients can easily access a telemedicine platform to participate in pilot 12 • Main groups of patients targeted are seen at Addenbrooke’s Lysosomal Disorder Unit (250 patients), Addenbrooke's Severe Insulin Resistance Clinic (150 patients) and Birmingham Children’s Hospital (280 patients) • Disseminated to patients via CRDN and other platforms Patients targeted • Examine the proportion of patients choosing different answers across each questions using pie charts and bar graphs • Compare the different segments of patients, based on age of patient and the clinic the patient is seen at Methods of analysis
  • 13. Percentage of respondents who are willing to participate in a telemedicine pilot ● Number of respondents: 67 ● 60% willing to participate in telemedicine trial (pilot) 13
  • 14. 14 Survey respondents believe that telemedicine will help them in a variety of ways
  • 15. Survey respondents portray a positive attitude towards usage of high-tech devices 15
  • 16. Necessary components of the pilot pose potential challenges for setup Essential factors for the pilot Operational requirements Legal requirements 16
  • 17. Proposal: Regional Case Managers One-stop shop service Single point of contact for advice, care and support PILOT Centre: NoRo Centre, Romania Target population: Patients with rare diseases Cases per manager: 30 (simultaneous) Time frame: 18 months (Jan 17–Jun 18) EURORDIS: European Organisation for Rare Diseases Source: Interview with Raquel Castro 17 EURORDIS’s InnovCare Project provided insight into designing a pilot study in Romania
  • 18. Source: Interview with Raquel Castro 18 The InnovCare project focuses on the role of case managers as a single point of contact for all patient needs • Single and stable point of contact: hub of information and knowledge • Listen, inform, support and empower patients and families, as well as professionals involved in care provision • Facilitating coordination between services and networks of service providers • Assessment/monitoring of needs, and observing those needs Role of case managers • Centre has existing provisions: physical therapy, speech therapy, training for staff, information and guidance services, etc. • Romanian healthcare system has a centralised software for patient files and data Existing infrastructure
  • 19. Challenges Administrative Case Managers considered “threatening” and interfering by care providers - Important to introduce in an appropriate way 19 Challenges faced while setting up the Romanian pilot were centred on obtaining robust technology Technological Limited/compromised access to internet, and insufficient connection for teleconferences Need at least one person to fix these problems
  • 20. OrangeHealth – setting up telemedicine projects in France (three regions) 20 Source: Interview with Andrew Green (OrangeHealth) Telemedicine pilot set up in France suggests companies for workflow software and teleconferencing software Infrastructure ● Workflow management ● Cloud-based patient file management ● Access to patient data ● Imaging systems ● Equipment: camera, screens, network connections Acceois provided the software for telemedicine workflow management Equatel provided robust teleconference terminals – links with monitoring equipment
  • 21. Operational requirements will require expansion of current infrastructure Operational requirements for telemedicine pilot Working infrastructure: working computers/tablets with cameras Seminar rooms/space for calls Internet connection Robust and secure: patient and specialist e-Health records Constant access to the patients files Reliable teleconference software complies with privacy regulations around access to records Source: CCN interviews with key opinion leaders and Scotland pilot program 21
  • 22. Legal infrastructure for Romanian pilot was governed by national regulations Data protection and legal infrastructure The NoRo centre has social service and healthcare provider status Source: Interview with Raquel Castro Patient files are under the control of the patient: patient decides, patient shares 22
  • 23. Telemedicine pilot set up in France by OrangeHealth focused on the efforts made to comply with data privacy Source: Interview with Andrew Green (OrangeHealth) 23 Data protection ● OrangeHealth provided virtual private network (VPN) ● OrangeCloud hosted data Took 2 years to get approval Issues: ● Full-time doctor availability ● Data duplication/back-up ● Data vulnerability ● Intrusion by external forces Both comply with France’s regulations
  • 24. Both hospitals being considered for the pilot have governance teams for ensuring data protection Birmingham Children’s Hospital Own Information Governance team, that complies with national data privacy regulations Addenbrooke’s Hospital Own Information Governance team, ensuring that patient information is dealt with legally and securely to appropriate ethical and quality standards (10 standards and requirements, including Health Records Management, Confidentiality and the Data Protection Act 1998) 24
  • 25. Impact of data protection and operational requirements on plans for telemedicine arrangements DATA PROTECTION Informed consent of pilot participants is important ● Main concern during group calls with consultant ● Patients may be uncomfortable with exposure to private data OPERATIONAL REQUIREMENTS Direct impact on all arrangements ● Equipment with camera is crucial ● E-health records must be available to the doctor in order to make best medical decisions 25
  • 26. Telemedicine arrangement formats (via video calls) Patient to specialist nurse/physician from patient’s home Small groups of patients to specialist doctor Patient at local GP to specialist nurse/physician Patient to specialist nurse/physician + remote monitoring of physiological parameters Proposed telemedicine arrangements have been narrowed down to four potential formats Source: CCN interviews with key opinion leaders 26
  • 27. Patient at local GP to specialist nurse/physician model may not get the GP buy-in necessary for success Source: Interview with Helena Baker (Medical Research Network) 27 1. GP workload prohibits taking on additional responsibility “The key issue with that model is you don’t get GP buy-in. The GPs are under such huge pressure, and when a patient has a rare disease, GPs very much want the consultants to come in and deal with that.” 2. Lack of education buy-in among GPs “There is a small cohort of GPs interested in continuing education and doing exciting new novel things like that – the vast majority won’t. But only 5% of GPs take part in clinical trials anyway.” 3. Logistical difficulty in lining up schedules Both GPs and consultants already sometimes face issues with scheduling, as clinics they have with patients sometimes start late. This will pose a significant challenge should both parties be involved in a given consultation.
  • 28. A 3-year telemedicine pilot programme in Cambridgeshire is likely to save £34 million by improving healthcare outcomes Source: WDS Headline Findings & The King’s Fund Publications. https://www.kingsfund.org.uk/publications/articles/kent-telehealth-pilot-study 28 Case study in Kent • As indicated in the pilot study, telemedicine could reduce clinician home visits, unplanned admissions and A&E visits • The 6-month pilot study has led to an average saving of £1,878 per patient Extrapolating to Cambridgeshire • A 3-year pilot programme in Cambridgeshire is therefore likely to save £1,878 x 6 = £11,268 per patient • Assuming 3,000 patients with rare diseases live in Cambridgeshire, the aggregate saving would be £34 million, plus improved health care outcomes • These figures further highlight the effectiveness of telemedicine in cost-savings
  • 29. Cost difference for each telemedicine meeting vs. in-person visit • Assume average travel costs around Cambridgeshire is £20 for a round trip • Assume each visit consumes 1 hour on the road and costs £44 for nurse hourly wage (not directly patient-related work) Compared to in-person visits by nurses, the use of a telemedicine platform could further save £44 costs per meeting Source: Unit Costs of Health and Social Care 2015; http://www.pssru.ac.uk/project-pages/unit-costs/2015/ Saving on travel-related costs: £64 Extra cost for telemedicine platform: £20 Each telemedicine meeting could save £64 - £20 = £44 • Market research indicates that telemedicine platforms (e.g. 1 Doc Way in the U.S.) cost c.£20/hour • Assume each telemedicine meeting lasts at most 1 hour 29
  • 30. 30 To construct a cost model for the pilot program, patient segmentation is performed on Addenbrooke’s and BCH, followed by fixed and variable cost projection Variable costs Fixed costs Equipment Overhead: Admin & IT staff Training Attributable nurse salary Additional data storage System maintenance and upgrade Installation Travel (reserve level) Addenbrooke's Hospital (N=650) ● Lysosomal/Metabolic Disorder Unit (500) ● Severe Insulin Resistance Unit (150) Birmingham Children’s Hospital (N=280) ● Autosomal Recessive Polycystic Kidney Diseases (80) ● Cystic Fibrosis (100) ● Tumour Suppressor Complex (100) Key assumptions ● UK internet access rate: 92% ● Initial adoption rate: 70% ● Annual dropout rate: 5% ● Additional buffer time for system handling: 15% ● Patient terminal: £405 ● Hospital terminal: £6,098 Source: World Bank, Frost & Sullivan, Unit Costs of Health and Social Care 2013 & 2015; http://www.pssru.ac.uk/project-pages/unit-costs/2015/
  • 31. Total cost of the 3-year pilot program is estimated at £975K, with equipment costs and specialist nurse salaries being major cost drivers, contributing to 31% and 28% of total cost, respectively % of total 31% 3% 4% 21% 28% 5% 5% 3% 100% • Given the high requirement of upfront infrastructure investment, fixed costs account for 59% of total costs • This further supports the idea of leveraging existing hardware resources, or procuring less customized telemedicine solutions as long as the healthcare effectiveness is not compromised 31
  • 32. Splitting costs along a timeline, initial setup costs take up 36% of total costs, with the remaining costs evenly distributed throughout the 3-year pilot program period • 61% of fixed costs will be incurred in the initial setup phase • This indicates the possibility to achieve greater economies of scale (i.e. lower costs on a per meeting basis) when the pilot program is extended to a longer period • CRDN may opt for applying to additional grants or forming partnerships to finance a longer program 32
  • 33. For cost containment, besides equipment procurement, overhead and data storage costs could further be reduced if IT and admin staff are outsourced and cloud storage is used Cost model summary for the 3-year telemedicine pilot program: Source (model assumptions): World Bank, Office for National Statistics, Orange Health, Cambridge Consultants, Unit Costs of Health and Social Care 2013 & 2015; http://www.pssru.ac.uk/project-pages/unit-costs/2015/ 33
  • 34. Potential benefits of the pilot program is projected to be £6.8M The telemedicine pilot program is estimated to bring 6.0x return on investments and thus represents strong financial saving potential • Extrapolating the cost-saving experience from Kent, a 3-year pilot study could lead to an average financial saving of £11,268 per patient • In the cost model, there would be 604 patients on average using the telemedicine platform throughout the program horizon • Therefore, the estimated benefits could amount to £11,268 X 604 =£6.80M 34 Estimated ROI = (£6.80M - £0.98M)/£0.98M = 6.0x
  • 35. Cost difference for each telemedicine meeting vs. in-person visit • Assume average travel costs around Cambridgeshire is £20 for a round trip • Assume each visit consumes 1 hour on the road and costs £44 for nurse hourly wage (not directly patient-related work) Compared to in-person visits by nurses, the use of a telemedicine platform could further save £44 costs per meeting Source: Unit Costs of Health and Social Care 2015; http://www.pssru.ac.uk/project-pages/unit-costs/2015/ Saving on travel-related costs: £64 Extra cost for telemedicine platform: £20 Each telemedicine meeting could save £64 - £20 = £44 • Market research indicates that telemedicine platforms (e.g. 1 Doc Way in the U.S.) cost c.£20/hour • Assume each telemedicine meeting lasts at most 1 hour 35
  • 36. Executive Summary ● There is strong demand for a telemedicine pilot program from rare disease patients. Our survey findings indicates that a majority of patients are receptive to a telemedicine pilot -- over 50% believe telemedicine will help them save money and time, while improving quality of care received. Over 90% of patients are willing to learn how to use video call applications. ● We identified four potential telemedicine models and key operational requirements. We recommend having Case Managers to act as a single point of contact for patients. Necessary infrastructure for the pilot should include (i) video conferencing capabilities and (ii) secure data protection. ● A 3-year telemedicine pilot program is estimated to bring at least £6.8M in healthcare cost savings while the project itself will cost approx. £975k. There is further scope for cost containment through outsourcing or using cloud storage. 36
  • 37. ‘This work has been undertaken as part of a student educational project and the material should be viewed in this context. The work does not constitute professional advice and no warranties are made regarding the information presented. Cambridge Consulting Network do not accept any liability for the consequences of any action taken as a result of the work or any recommendations made or inferred’ Thank you Natalie Rebeyev: nr406am.ac.uk Saakshi Chadha: sc885@cam.ac.uk 37